Translocation (4;11) in acute myelogenous leukemia

Area of Science:

• Hematology
• Cytogenetics
• Pediatric Oncology

Background:

• Acute Myelogenous Leukemia (AML) is a heterogeneous group of myeloid stem cell disorders.
• The t(4;11) translocation is a known cytogenetic abnormality associated with certain subtypes of acute leukemia.
• Understanding the genetic basis of AML is crucial for diagnosis and prognosis.

Observation:

• A pediatric case of acute myelogenous leukemia is presented.
• Cytogenetic analysis of the patient's leukemic cells identified a specific translocation: (4;11)(q12;q23).
• A subtle variation in the breakpoint on chromosome 4, compared to previously documented t(4;11) cases, was noted.

Findings:

• The observed t(4;11) translocation in this AML case is linked to a unique subgroup of leukemia.
• This specific genetic abnormality appears to influence the degree of myeloid differentiation observed in the leukemic cells.
• The origin of this leukemia subtype is traced back to an early myeloid stem cell.

Implications:

• The t(4;11) translocation is associated with a poor prognosis in acute leukemia.
• This case highlights the importance of precise cytogenetic analysis in classifying AML subtypes.
• Further research into the molecular mechanisms underlying t(4;11) AML may reveal novel therapeutic targets.